Healthcare

EMEA (Europe, Middle East and Africa) Oncology Drugs Market Report 2017

  • QYR1564600
  • 101 Pages
  • September 2017
  • Healthcare
Download Sample    Get Discount   
 
In this report, the EMEA Oncology Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Oncology Drugs for these regions, from 2012 to 2022 (forecast)

Europe: Germany, France, UK, Russia, Italy and Benelux;

Middle East: Saudi Arabia, Israel, UAE and Iran;

Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oncology Drugs market competition by top manufacturers/players, with Oncology Drugs sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

Novartis A.G

Laboratrio Cristlia

Medley Genomics

F. Hoffmann-La Roche Ltd

Icon Plc.

Sanofi S.A.

Laboratoires Pierre Fabre

Eurofarma Laboratrios S.A.

Ach Laboratrios Farmacuticos S.A.

Laboratorios IMA

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

Oral Therapy

Injectable Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Oncology Drugs for each application, including

Targeted Therapy

Chemotherapy

Hormonal Therapy

Biologic Therapy

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Oncology Drugs Market Report 2017

1 Oncology Drugs Overview

1.1 Product Overview and Scope of Oncology Drugs

1.2 Classification of Oncology Drugs

1.2.1 EMEA Oncology Drugs Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 EMEA Oncology Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Oral Therapy

1.2.4 Injectable Therapy

1.3 EMEA Oncology Drugs Market by Application/End Users

1.3.1 EMEA Oncology Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022

1.3.2 Targeted Therapy

1.3.3 Chemotherapy

1.3.4 Hormonal Therapy

1.3.5 Biologic Therapy

1.4 EMEA Oncology Drugs Market by Region

1.4.1 EMEA Oncology Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 Europe Status and Prospect (2012-2022)

1.4.3 Middle East Status and Prospect (2012-2022)

1.4.4 Africa Status and Prospect (2012-2022)

1.5 EMEA Market Size (Value and Volume) of Oncology Drugs (2012-2022)

1.5.1 EMEA Oncology Drugs Sales and Growth Rate (2012-2022)

1.5.2 EMEA Oncology Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Oncology Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application

2.1 EMEA Oncology Drugs Market Competition by Players/Manufacturers

2.1.1 EMEA Oncology Drugs Sales Volume and Market Share of Major Players (2012-2017)

2.1.2 EMEA Oncology Drugs Revenue and Share by Players (2012-2017)

2.1.3 EMEA Oncology Drugs Sale Price by Players (2012-2017)

2.2 EMEA Oncology Drugs (Volume and Value) by Type/Product Category

2.2.1 EMEA Oncology Drugs Sales and Market Share by Type (2012-2017)

2.2.2 EMEA Oncology Drugs Revenue and Market Share by Type (2012-2017)

2.2.3 EMEA Oncology Drugs Sale Price by Type (2012-2017)

2.3 EMEA Oncology Drugs (Volume) by Application

2.4 EMEA Oncology Drugs (Volume and Value) by Region

2.4.1 EMEA Oncology Drugs Sales and Market Share by Region (2012-2017)

2.4.2 EMEA Oncology Drugs Revenue and Market Share by Region (2012-2017)

2.4.3 EMEA Oncology Drugs Sales Price by Region (2012-2017)

3 Europe Oncology Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application

3.1 Europe Oncology Drugs Sales and Value (2012-2017)

3.1.1 Europe Oncology Drugs Sales Volume and Growth Rate (2012-2017)

3.1.2 Europe Oncology Drugs Revenue and Growth Rate (2012-2017)

3.2 Europe Oncology Drugs Sales and Market Share by Type

3.3 Europe Oncology Drugs Sales and Market Share by Application

3.4 Europe Oncology Drugs Sales Volume and Value (Revenue) by Countries

3.4.1 Europe Oncology Drugs Sales Volume by Countries (2012-2017)

3.4.2 Europe Oncology Drugs Revenue by Countries (2012-2017)

3.4.3 Germany Oncology Drugs Sales and Growth Rate (2012-2017)

3.4.4 France Oncology Drugs Sales and Growth Rate (2012-2017)

3.4.5 UK Oncology Drugs Sales and Growth Rate (2012-2017)

3.4.6 Russia Oncology Drugs Sales and Growth Rate (2012-2017)

3.4.7 Italy Oncology Drugs Sales and Growth Rate (2012-2017)

3.4.8 Benelux Oncology Drugs Sales and Growth Rate (2012-2017)

4 Middle East Oncology Drugs (Volume, Value and Sales Price), by Region, Type and Application

4.1 Middle East Oncology Drugs Sales and Value (2012-2017)

4.1.1 Middle East Oncology Drugs Sales Volume and Growth Rate (2012-2017)

4.1.2 Middle East Oncology Drugs Revenue and Growth Rate (2012-2017)

4.2 Middle East Oncology Drugs Sales and Market Share by Type

4.3 Middle East Oncology Drugs Sales and Market Share by Application

4.4 Middle East Oncology Drugs Sales Volume and Value (Revenue) by Countries

4.4.1 Middle East Oncology Drugs Sales Volume by Countries (2012-2017)

4.4.2 Middle East Oncology Drugs Revenue by Countries (2012-2017)

4.4.3 Saudi Arabia Oncology Drugs Sales and Growth Rate (2012-2017)

4.4.4 Israel Oncology Drugs Sales and Growth Rate (2012-2017)

4.4.5 UAE Oncology Drugs Sales and Growth Rate (2012-2017)

4.4.6 Iran Oncology Drugs Sales and Growth Rate (2012-2017)

5 Africa Oncology Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application

5.1 Africa Oncology Drugs Sales and Value (2012-2017)

5.1.1 Africa Oncology Drugs Sales Volume and Growth Rate (2012-2017)

5.1.2 Africa Oncology Drugs Revenue and Growth Rate (2012-2017)

5.2 Africa Oncology Drugs Sales and Market Share by Type

5.3 Africa Oncology Drugs Sales and Market Share by Application

5.4 Africa Oncology Drugs Sales Volume and Value (Revenue) by Countries

5.4.1 Africa Oncology Drugs Sales Volume by Countries (2012-2017)

5.4.2 Africa Oncology Drugs Revenue by Countries (2012-2017)

5.4.3 South Africa Oncology Drugs Sales and Growth Rate (2012-2017)

5.4.4 Nigeria Oncology Drugs Sales and Growth Rate (2012-2017)

5.4.5 Egypt Oncology Drugs Sales and Growth Rate (2012-2017)

5.4.6 Algeria Oncology Drugs Sales and Growth Rate (2012-2017)

6 EMEA Oncology Drugs Manufacturers/Players Profiles and Sales Data

6.1 Novartis A.G

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Oncology Drugs Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Novartis A.G Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Laboratrio Cristlia

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Oncology Drugs Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Laboratrio Cristlia Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Medley Genomics

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Oncology Drugs Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Medley Genomics Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 F. Hoffmann-La Roche Ltd

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Oncology Drugs Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 F. Hoffmann-La Roche Ltd Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Icon Plc.

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Oncology Drugs Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Icon Plc. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Sanofi S.A.

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Oncology Drugs Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Sanofi S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Laboratoires Pierre Fabre

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Oncology Drugs Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Laboratoires Pierre Fabre Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Eurofarma Laboratrios S.A.

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Oncology Drugs Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Eurofarma Laboratrios S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Ach Laboratrios Farmacuticos S.A.

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Oncology Drugs Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Laboratorios IMA

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Oncology Drugs Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Laboratorios IMA Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Oncology Drugs Manufacturing Cost Analysis

7.1 Oncology Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Oncology Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Oncology Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 EMEA Oncology Drugs Market Forecast (2017-2022)

11.1 EMEA Oncology Drugs Sales, Revenue and Price Forecast (2017-2022)

11.1.1 EMEA Oncology Drugs Sales and Growth Rate Forecast (2017-2022)

11.1.2 EMEA Oncology Drugs Revenue and Growth Rate Forecast (2017-2022)

11.1.3 EMEA Oncology Drugs Price and Trend Forecast (2017-2022)

11.2 EMEA Oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.3 Europe Oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.4 Middle Eastt Oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.5 Africa Oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.6 EMEA Oncology Drugs Sales Forecast by Type (2017-2022)

11.7 EMEA Oncology Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Oncology Drugs

Figure EMEA Oncology Drugs Sales Volume (MT) by Type (2012-2022)

Figure EMEA Oncology Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Oral Therapy Product Picture

Figure Injectable Therapy Product Picture

Figure EMEA Oncology Drugs Sales Volume (MT) by Application (2012-2022)

Figure EMEA Sales Market Share of Oncology Drugs by Application in 2016

Figure Targeted Therapy Examples

Table Key Downstream Customer in Targeted Therapy

Figure Chemotherapy Examples

Table Key Downstream Customer in Chemotherapy

Figure Hormonal Therapy Examples

Table Key Downstream Customer in Hormonal Therapy

Figure Biologic Therapy Examples

Table Key Downstream Customer in Biologic Therapy

Figure EMEA Oncology Drugs Market Size (Million USD) by Region (2012-2022)

Figure Europe Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Oncology Drugs Revenue (Million USD) Status and Forecast by Countries

Figure Middle East Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Middle East Oncology Drugs Revenue (Million USD) Status and Forecast by Countries

Figure Africa Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Africa Oncology Drugs Revenue (Million USD) Status and Forecast by Countries

Figure EMEA Oncology Drugs Sales Volume and Growth Rate (2012-2022)

Figure EMEA Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure EMEA Oncology Drugs Market Major Players Product Sales Volume (MT) (2012-2017)

Table EMEA Oncology Drugs Sales Volume (MT) of Major Players (2012-2017)

Table EMEA Oncology Drugs Sales Share by Players (2012-2017)

Figure 2016 Oncology Drugs Sales Share by Players

Figure 2017 Oncology Drugs Sales Share by Players

Figure EMEA Oncology Drugs Market Major Players Product Revenue (Million USD) (2012-2017)

Table EMEA Oncology Drugs Revenue (Million USD) by Players (2012-2017)

Table EMEA Oncology Drugs Revenue Share by Players (2012-2017)

Table 2016 EMEA Oncology Drugs Revenue Share by Players

Table 2017 EMEA Oncology Drugs Revenue Share by Players

Table EMEA Oncology Drugs Sale Price (USD/Kg) by Players (2012-2017)

Table EMEA Oncology Drugs Sales (MT) and Market Share by Type (2012-2017)

Table EMEA Oncology Drugs Sales Share by Type (2012-2017)

Figure Sales Market Share of Oncology Drugs by Type (2012-2017)

Figure EMEA Oncology Drugs Sales Market Share by Type (2012-2017)

Table EMEA Oncology Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table EMEA Oncology Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Oncology Drugs by Type in 2016

Table EMEA Oncology Drugs Sale Price (USD/Kg) by Type (2012-2017)

Table EMEA Oncology Drugs Sales (MT) and Market Share by Application (2012-2017)

Table EMEA Oncology Drugs Sales Share by Application (2012-2017)

Figure Sales Market Share of Oncology Drugs by Application (2012-2017)

Figure EMEA Oncology Drugs Sales Market Share by Application in 2016

Table EMEA Oncology Drugs Sales (MT) and Market Share by Region (2012-2017)

Table EMEA Oncology Drugs Sales Share by Region (2012-2017)

Figure Sales Market Share of Oncology Drugs by Region (2012-2017)

Figure EMEA Oncology Drugs Sales Market Share in 2016

Table EMEA Oncology Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table EMEA Oncology Drugs Revenue Share by Region (2012-2017)

Figure Revenue Market Share of Oncology Drugs by Region (2012-2017)

Figure EMEA Oncology Drugs Revenue Market Share Regions in 2016

Table EMEA Oncology Drugs Sales Price (USD/Kg) by Region (2012-2017)

Figure Europe Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Europe Oncology Drugs Revenue and Growth Rate (2012-2017)

Table Europe Oncology Drugs Sales (MT) by Type (2012-2017)

Table Europe Oncology Drugs Market Share by Type (2012-2017)

Figure Europe Oncology Drugs Market Share by Type in 2016

Table Europe Oncology Drugs Sales (MT) by Application (2012-2017)

Table Europe Oncology Drugs Market Share by Application (2012-2017)

Figure Europe Oncology Drugs Market Share by Application in 2016

Table Europe Oncology Drugs Sales (MT) by Countries (2012-2017)

Table Europe Oncology Drugs Sales Market Share by Countries (2012-2017)

Figure Europe Oncology Drugs Sales Market Share by Countries (2012-2017)

Figure Europe Oncology Drugs Sales Market Share by Countries in 2016

Table Europe Oncology Drugs Revenue (Million USD) by Countries (2012-2017)

Table Europe Oncology Drugs Revenue Market Share by Countries (2012-2017)

Figure Europe Oncology Drugs Revenue Market Share by Countries (2012-2017)

Figure Europe Oncology Drugs Revenue Market Share by Countries in 2016

Figure Germany Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure France Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure UK Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Russia Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Italy Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Benelux Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Middle East Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Middle East Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Table Middle East Oncology Drugs Sales (MT) by Type (2012-2017)

Table Middle East Oncology Drugs Market Share by Type (2012-2017)

Figure Middle East Oncology Drugs Market Share by Type (2012-2017)

Table Middle East Oncology Drugs Sales (MT) by Applications (2012-2017)

Table Middle East Oncology Drugs Market Share by Applications (2012-2017)

Figure Middle East Oncology Drugs Sales Market Share by Application in 2016

Table Middle East Oncology Drugs Sales Volume (MT) by Countries (2012-2017)

Table Middle East Oncology Drugs Sales Volume Market Share by Countries (2012-2017)

Figure Middle East Oncology Drugs Sales Volume Market Share by Countries in 2016

Table Middle East Oncology Drugs Revenue (Million USD) by Countries (2012-2017)

Table Middle East Oncology Drugs Revenue Market Share by Countries (2012-2017)

Figure Middle East Oncology Drugs Revenue Market Share by Countries (2012-2017)

Figure Middle East Oncology Drugs Revenue Market Share by Countries in 2016

Figure Saudi Arabia Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Israel Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure UAE Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Iran Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Africa Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Africa Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Table Africa Oncology Drugs Sales (MT) by Type (2012-2017)

Table Africa Oncology Drugs Sales Market Share by Type (2012-2017)

Figure Africa Oncology Drugs Sales Market Share by Type (2012-2017)

Figure Africa Oncology Drugs Sales Market Share by Type in 2016

Table Africa Oncology Drugs Sales (MT) by Application (2012-2017)

Table Africa Oncology Drugs Sales Market Share by Application (2012-2017)

Figure Africa Oncology Drugs Sales Market Share by Application (2012-2017)

Table Africa Oncology Drugs Sales Volume (MT) by Countries (2012-2017)

Table Africa Oncology Drugs Sales Market Share by Countries (2012-2017)

Figure Africa Oncology Drugs Sales Market Share by Countries (2012-2017)

Figure Africa Oncology Drugs Sales Market Share by Countries in 2016

Table Africa Oncology Drugs Revenue (Million USD) by Countries (2012-2017)

Table Africa Oncology Drugs Revenue Market Share by Countries (2012-2017)

Figure Africa Oncology Drugs Revenue Market Share by Countries (2012-2017)

Figure Africa Oncology Drugs Revenue Market Share by Countries in 2016

Figure South Africa Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Nigeria Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Egypt Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Algeria Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Table Novartis A.G Oncology Drugs Basic Information List

Table Novartis A.G Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Novartis A.G Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Novartis A.G Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure Novartis A.G Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table Laboratrio Cristlia Oncology Drugs Basic Information List

Table Laboratrio Cristlia Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Laboratrio Cristlia Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Laboratrio Cristlia Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure Laboratrio Cristlia Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table Medley Genomics Oncology Drugs Basic Information List

Table Medley Genomics Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Medley Genomics Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Medley Genomics Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure Medley Genomics Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table F. Hoffmann-La Roche Ltd Oncology Drugs Basic Information List

Table F. Hoffmann-La Roche Ltd Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure F. Hoffmann-La Roche Ltd Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure F. Hoffmann-La Roche Ltd Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure F. Hoffmann-La Roche Ltd Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table Icon Plc. Oncology Drugs Basic Information List

Table Icon Plc. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Icon Plc. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Icon Plc. Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure Icon Plc. Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table Sanofi S.A. Oncology Drugs Basic Information List

Table Sanofi S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Sanofi S.A. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Sanofi S.A. Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure Sanofi S.A. Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table Laboratoires Pierre Fabre Oncology Drugs Basic Information List

Table Laboratoires Pierre Fabre Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Laboratoires Pierre Fabre Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Laboratoires Pierre Fabre Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure Laboratoires Pierre Fabre Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table Eurofarma Laboratrios S.A. Oncology Drugs Basic Information List

Table Eurofarma Laboratrios S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Eurofarma Laboratrios S.A. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Eurofarma Laboratrios S.A. Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure Eurofarma Laboratrios S.A. Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table Ach Laboratrios Farmacuticos S.A. Oncology Drugs Basic Information List

Table Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table Laboratorios IMA Oncology Drugs Basic Information List

Table Laboratorios IMA Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Laboratorios IMA Oncology Drugs Sales (MT) and Growth Rate (2012-2017)

Figure Laboratorios IMA Oncology Drugs Sales Market Share in EMEA (2012-2017)

Figure Laboratorios IMA Oncology Drugs Revenue Market Share in EMEA (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Oncology Drugs

Figure Manufacturing Process Analysis of Oncology Drugs

Figure Oncology Drugs Industrial Chain Analysis

Table Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016

Table Major Buyers of Oncology Drugs

Table Distributors/Traders List

Figure EMEA Oncology Drugs Sales (MT) and Growth Rate Forecast (2017-2022)

Figure EMEA Oncology Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure EMEA Oncology Drugs Price (USD/Kg) and Trend Forecast (2017-2022)

Table EMEA Oncology Drugs Sales (MT) Forecast by Region (2017-2022)

Figure EMEA Oncology Drugs Sales Market Share Forecast by Region (2017-2022)

Table EMEA Oncology Drugs Revenue (Million USD) Forecast by Region (2017-2022)

Figure EMEA Oncology Drugs Revenue Market Share Forecast by Region (2017-2022)

Table Europe Oncology Drugs Sales (MT) Forecast by Countries (2017-2022)

Figure Europe Oncology Drugs Sales Market Share Forecast by Countries (2017-2022)

Table Europe Oncology Drugs Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Europe Oncology Drugs Revenue Market Share Forecast by Countries (2017-2022)

Table Middle East Oncology Drugs Sales (MT) Forecast by Countries (2017-2022)

Figure Middle East Oncology Drugs Sales Market Share Forecast by Countries (2017-2022)

Table Middle East Oncology Drugs Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Middle East Oncology Drugs Revenue Market Share Forecast by Countries (2017-2022)

Table Africa Oncology Drugs Sales (MT) Forecast by Countries (2017-2022)

Figure Africa Oncology Drugs Sales Market Share Forecast by Countries (2017-2022)

Table Africa Oncology Drugs Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Africa Oncology Drugs Revenue Market Share Forecast by Countries (2017-2022)

Table EMEA Oncology Drugs Sales (MT) Forecast by Type (2017-2022)

Figure EMEA Oncology Drugs Sales Market Share Forecast by Type (2017-2022)

Table EMEA Oncology Drugs Sales (MT) Forecast by Application (2017-2022)

Figure EMEA Oncology Drugs Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370